N-Glycosylation Regulates Fibroblast Growth Factor Receptor/EGL-15 Activity in Caenorhabditis elegans in Vivo*

N-Glycosylation Regulates Fibroblast Growth Factor Receptor/EGL-15 Activity in Caenorhabditis elegans in Vivo*
复制标题

N-糖基化调节秀丽隐杆线虫体内成纤维细胞生长因子受体/EGL-15 活性*

DOI:
--
复制
发表时间:
2009
影响因子:
4.8
通讯作者:
T. Kinnunen
T. Kinnunen
中科院分区:
生物学2区
文献类型:
--
作者:
U. Polanska;L. Duchesne;Janet C. Harries;D. Fernig;T. Kinnunen

文献摘要

参考文献

被引文献

相似文献

成纤维细胞生长因子(FGFs)对细胞功能的调节通常是通过酪氨酸激酶受体(FGFR)和硫酸肝素蛋白聚糖共受体的双受体系统发生的。人类FGFR中一些一致的n -糖基化位点的突变可导致骨骼疾病和颅缝闭综合征,体外生物物理学研究表明,FGFR的n -糖基化改变了配体和硫酸肝素的结合特性。秀丽隐杆线虫进化上保守的FGFR信号系统已被用于评估n -糖基化在体内调节FGFR信号传导中的作用。线虫FGF受体EGL-15在体内被n -糖基化,特定一致n -糖基化位点的遗传替代导致液体稳态维持和性肌分化的缺陷,这两种表型先前都与EGL-15信号过度活跃相关。这些表型分别被EGL-15下游信号成分的低活性突变或磷脂酰肌醇3-激酶途径的激活突变所抑制。结果表明,n -聚糖在体内负调控FGFR活性,支持了人类FGFR中n -糖基化位点突变可能导致受体不适当激活的观点。
The regulation of cell function by fibroblast growth factors (FGFs) classically occurs through a dual receptor system of a tyrosine kinase receptor (FGFR) and a heparan sulfate proteoglycan co-receptor. Mutations in some consensus N-glycosylation sites in human FGFR result in skeletal disorders and craniosynostosis syndromes, and biophysical studies in vitro suggest that N-glycosylation of FGFR alters ligand and heparan sulfate binding properties. The evolutionarily conserved FGFR signaling system of Caenorhabditis elegans has been used to assess the role of N-glycosylation in the regulation of FGFR signaling in vivo. The C. elegans FGF receptor, EGL-15, is N-glycosylated in vivo, and genetic substitution of specific consensus N-glycosylation sites leads to defects in the maintenance of fluid homeostasis and differentiation of sex muscles, both of which are phenotypes previously associated with hyperactive EGL-15 signaling. These phenotypes are suppressed by hypoactive mutations in EGL-15 downstream signaling components or activating mutations in the phosphatidylinositol 3-kinase pathway, respectively. The results show that N-glycans negatively regulate FGFR activity in vivo supporting the notion that mutation of N-glycosylation sites in human FGFR may lead to inappropriate activation of the receptor.
DOI: 10.1016/j.ydbio.2008.03.026
发表时间: 2008
影响因子: 2.7
作者:
Lo,Te-Wen;Branda,CatherineS;Huang,Peng;Sasson,IsaacE;Goodman,SJay;Stern,MichaelJ
通讯作者: Stern,MichaelJ
DOI: 10.1086/427956
发表时间: 2005-02-01
影响因子: 9.8
作者:
White, KE;Cabral, JM;Econs, MJ
通讯作者: Econs, MJ
DOI: 10.1002/j.1460-2075.1991.tb04966.x
发表时间: 1991-12-01
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
MELLO, CC;KRAMER, JM;AMBROS, V
通讯作者: AMBROS, V